EventsMOL2NET'19, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 5th ed.
Event submissions
Published
with-doi10.3390/mol2net-05-06238
This submission belongs to the session 02. USINEWS-03: US-IN-EU Worldwide Science Workshop Series, UMN, Duluth, USA, 2019 of the event MOL2NET'19, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 5th ed.
Published date
04 Jul, 2019
Citation
Laura Jauregui, Use of Cannabis sativa L. for the treatment of Alzheimer's disease, in Proceedings of MOL2NET'19, Conference on Molecular, Biomed., Comput. & Network Science and Engineering, 5th ed., 20 March–20 December 2019, MDPI: Basel, Switzerland, doi: 10.3390/mol2net-05-06238
Share
Email
Facebook
Twitter
LinkedIn

Use of Cannabis sativa L. for the treatment of Alzheimer's disease

image
Laura Jauregui 1
1. Universidad de Guanajuato
Abstract

Alzheimer´s Disease (AD) is a neurodegenerative disorder which represents a problem for the public health system because it affects more than 50 million people in the world, currently there is no successful treatment to treat this disease. The most accepted hypothesis regarding the development of this disease is the accumulation of plaques Aβ in the brain, have studied different molecules of natural origin as treatment based on this hypothesis. Cannabis sativa L. is a plant that has great potential as a treatment for this disease due to its antioxidant and neuroprotective properties and it has been shown to reduce the accumulation of Aβ plaques.

Keywords
Alzheimer´s disease
Cannabis
Neuroprotection
Manuscript
mol2net-03_MOL2NET-2017-template.pdf
Medicinal plants extract for cancer treatment
Nanoemulsions as coadyuvants in intranasal vaccines